• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺分泌性癌:一例报告。

Secretory carcinoma of the breast: A case report.

作者信息

Pohlodek Kamil, Mečiarová Iveta, Grossmann Petr, Martínek Petr, Kinkor Zdeněk

机构信息

2nd Department of Gynecology and Obstetrics, Faculty of Medicine, Comenius University of Bratislava, Slovakia.

Alpha Medical Pathology Ltd., Bratislava, Slovakia.

出版信息

Int J Surg Case Rep. 2019;56:74-77. doi: 10.1016/j.ijscr.2019.02.029. Epub 2019 Feb 28.

DOI:10.1016/j.ijscr.2019.02.029
PMID:30852371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407075/
Abstract

INTRODUCTION

Secretory breast carcinoma (SBC) is a rare breast tumor which accounts for < 0.15% of all breast cancers. It was originally described as a juvenile breast carcinoma, occurring in young children and adolescent women. SBC is associated with a characteristic balanced translocation, t(12;15), that creates aETV6-NTRK3 gene fusion.

PRESENTATION OF CASE

A 52-year-old Caucasian woman had palpable lump in her right breast. After breast imaging examination (BI-RADS 4b) and preoperative core-needle biopsy with suspicion of SBC a breast conserving therapy was performed. The diagnosis of SBC was confirmed through immunohistochemistry and cytogenetic examination of the tumor. The patient is now 22 months post‑surgery and remains disease‑free.

DISCUSSION

Recent studies reported that the disease occurs at a later age than previously recognized, and is associated with good long-term survival. In breast imaging it may mimic a benign tumor. Immunohistochemistry and cytogenetic analysis of the tumor are crucial for confirmation of SBC.

CONCLUSION

There is no consensus with regard to the best treatment strategy for patients with SBC. Breast conserving therapy with sentinel lymph nodes biopsy is at present the first choice treatment. Further research for a specific NTRK3 tyrosine kinase inhibitor could lead to the discovery of a new targeted treatment of this tumor.

摘要

引言

分泌性乳腺癌(SBC)是一种罕见的乳腺肿瘤,占所有乳腺癌的比例不到0.15%。它最初被描述为一种青少年乳腺癌,发生于儿童和青春期女性。SBC与一种特征性的平衡易位t(12;15)相关,该易位产生ETV6-NTRK3基因融合。

病例介绍

一名52岁的白人女性右乳可触及肿块。在进行乳腺影像检查(BI-RADS 4b)并经术前粗针活检怀疑为SBC后,实施了保乳治疗。通过对肿瘤进行免疫组织化学和细胞遗传学检查确诊为SBC。患者目前术后22个月,无疾病复发。

讨论

最近的研究报告称,该疾病的发病年龄比之前认为的要晚,且与良好的长期生存率相关。在乳腺影像检查中,它可能类似良性肿瘤。对肿瘤进行免疫组织化学和细胞遗传学分析对于确诊SBC至关重要。

结论

对于SBC患者的最佳治疗策略尚无共识。目前,保乳治疗加前哨淋巴结活检是首选治疗方法。对特定的NTRK3酪氨酸激酶抑制剂进行进一步研究可能会发现针对这种肿瘤的新的靶向治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3d/6407075/10723832a9dc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3d/6407075/23092557d1ab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3d/6407075/10723832a9dc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3d/6407075/23092557d1ab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e3d/6407075/10723832a9dc/gr2.jpg

相似文献

1
Secretory carcinoma of the breast: A case report.乳腺分泌性癌:一例报告。
Int J Surg Case Rep. 2019;56:74-77. doi: 10.1016/j.ijscr.2019.02.029. Epub 2019 Feb 28.
2
Secretory breast carcinoma in a 12-year-old girl: A case report.一名12岁女孩的分泌性乳腺癌:病例报告。
Oncol Lett. 2014 Oct;8(4):1635-1637. doi: 10.3892/ol.2014.2380. Epub 2014 Jul 24.
3
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.分泌型乳腺癌中ETV6-NTRK3融合基因的荧光原位杂交研究
Genes Chromosomes Cancer. 2004 Jun;40(2):152-7. doi: 10.1002/gcc.20028.
4
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.分泌性乳腺癌:一种以特异性ETV6-NTRK3基因融合为特征的组织病理学和基因组谱。
Am J Surg Pathol. 2015 Nov;39(11):1458-67. doi: 10.1097/PAS.0000000000000487.
5
Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report.乳腺分泌性癌酷似浸润性导管癌 1 例报告
Am J Case Rep. 2022 Aug 19;23:e936665. doi: 10.12659/AJCR.936665.
6
Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection.一名6岁女孩的分泌性乳腺癌:乳房切除术加前哨淋巴结清扫术。
Pediatr Surg Int. 2015 Jul;31(7):677-81. doi: 10.1007/s00383-015-3721-0. Epub 2015 May 21.
7
Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature.乳腺分泌性癌通常表现为低级别三阴性乳腺癌的特征——一例病例报告及文献综述更新
Autops Case Rep. 2020 Dec 8;11:e2020227. doi: 10.4322/acr.2020.227. eCollection 2021.
8
Secretory breast carcinoma in an 8-year-old girl: A case report and literature review.一名8岁女孩的分泌性乳腺癌:病例报告及文献综述
Breast J. 2018 Nov;24(6):1055-1061. doi: 10.1111/tbj.13126. Epub 2018 Sep 24.
9
Secretory breast carcinoma in a 41-year-old man with long-term follow-up: a special report.一名41岁男性分泌性乳腺癌的长期随访:一份特别报告。
Future Oncol. 2015;11(12):1767-73. doi: 10.2217/fon.15.60.
10
Secretory carcinoma of male breast: case report and review of the literature.男性乳腺分泌性癌:病例报告及文献复习
Int J Breast Cancer. 2011;2011:704657. doi: 10.4061/2011/704657. Epub 2011 Feb 6.

引用本文的文献

1
A rare ER-positive secretory breast carcinoma: diagnostic challenges and surgical treatment.一例罕见的雌激素受体阳性分泌性乳腺癌:诊断挑战与外科治疗
Ann Med Surg (Lond). 2025 Jun 23;87(8):5257-5260. doi: 10.1097/MS9.0000000000003490. eCollection 2025 Aug.
2
Mastopexy for secretory carcinoma of breast in a young female: a case report.年轻女性乳腺分泌性癌的乳房固定术:一例报告
J Surg Case Rep. 2024 Jun 11;2024(6):rjae351. doi: 10.1093/jscr/rjae351. eCollection 2024 Jun.
3
Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools.

本文引用的文献

1
NTRK fusion-positive cancers and TRK inhibitor therapy.NTRK 融合阳性癌症和 TRK 抑制剂治疗。
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747. doi: 10.1038/s41571-018-0113-0.
2
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.拉罗替尼治疗携带 NTRK 基因融合的儿科实体瘤:多中心、开放标签、1 期/2 期研究的 1 期结果。
Lancet Oncol. 2018 May;19(5):705-714. doi: 10.1016/S1470-2045(18)30119-0. Epub 2018 Mar 29.
3
The SCARE Statement: Consensus-based surgical case report guidelines.
乳腺疾病的分子病理学:诊断、预后和治疗工具。
Virchows Arch. 2024 Feb;484(2):247-261. doi: 10.1007/s00428-023-03709-0. Epub 2023 Nov 28.
4
Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report.乳腺分泌性癌酷似浸润性导管癌 1 例报告
Am J Case Rep. 2022 Aug 19;23:e936665. doi: 10.12659/AJCR.936665.
5
A Case of Secretory Carcinoma in a Patient With a History of Contralateral Medullary Carcinoma.一例有对侧髓样癌病史患者的分泌性癌病例。
Cancer Diagn Progn. 2022 Jan 3;2(1):87-92. doi: 10.21873/cdp.10081. eCollection 2022 Jan-Feb.
6
Rare epithelial breast cancer: surgery and adjuvant therapy.罕见上皮性乳腺癌:手术及辅助治疗
Transl Cancer Res. 2019 Oct;8(Suppl 5):S479-S492. doi: 10.21037/tcr.2019.05.12.
7
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis.具有良好预后的三阴性乳腺癌组织学亚型
Cancers (Basel). 2021 Nov 14;13(22):5694. doi: 10.3390/cancers13225694.
SCARE 声明:基于共识的外科手术病例报告指南。
Int J Surg. 2016 Oct;34:180-186. doi: 10.1016/j.ijsu.2016.08.014. Epub 2016 Sep 7.
4
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.分泌性乳腺癌:一种以特异性ETV6-NTRK3基因融合为特征的组织病理学和基因组谱。
Am J Surg Pathol. 2015 Nov;39(11):1458-67. doi: 10.1097/PAS.0000000000000487.
5
Secretory breast carcinoma in a 41-year-old man with long-term follow-up: a special report.一名41岁男性分泌性乳腺癌的长期随访:一份特别报告。
Future Oncol. 2015;11(12):1767-73. doi: 10.2217/fon.15.60.
6
Secretory breast carcinoma in a 12-year-old girl: A case report.一名12岁女孩的分泌性乳腺癌:病例报告。
Oncol Lett. 2014 Oct;8(4):1635-1637. doi: 10.3892/ol.2014.2380. Epub 2014 Jul 24.
7
Secretory breast carcinoma: A report of three cases and a review of the literature.分泌性乳腺癌:三例报告并文献复习
Oncol Lett. 2014 Aug;8(2):683-686. doi: 10.3892/ol.2014.2213. Epub 2014 Jun 3.
8
Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.乳腺分泌性癌:来自生存、流行病学和结局数据库的结果。
Breast. 2012 Jun;21(3):350-3. doi: 10.1016/j.breast.2012.02.013. Epub 2012 Apr 10.
9
Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.分泌型乳腺癌:一种独特的三阴性乳腺癌,具有良好的预后和特征性的分子表达。
Arch Pathol Lab Med. 2011 Dec;135(12):1606-10. doi: 10.5858/arpa.2010-0351-RS.
10
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.具有ETV6-NTRK3融合基因的分泌性乳腺癌属于基底样癌谱系。
Mod Pathol. 2009 Feb;22(2):291-8. doi: 10.1038/modpathol.2008.184. Epub 2008 Nov 14.